This blog is not affiliated or endorsed, by Nassau OTB, a public benefit corporation, subject to the New York Freedom
of Information Law, NY Pub Off Law Sec 84 et seq.
moves to save lightly populated areas of New York with more gambling.
Nassau County Ed Mangano attempts to stave off Puerto Rico style reorganization, eg Chapter 9, bankruptcy with one thousand slot machines and a jet plane on the tarmac for points unknown.
Ordinary people contemplate the end of the world and leave Nassau County for North Carolina. Surf is up.
Revenue fell to $3.41 billion last month, the Asian
gambling hub's first year-over-year decline since the aftermath of the
financial crisis.
Bloomberg News
HONG KONG—Gambling revenue in Macau
fell 3.7% in June compared with a year earlier, handing the Asian
gambling hub its first year-over-year decline since the aftermath of the
financial crisis.
Revenue fell to 27.22
billion patacas ($3.41 billion) last month from 28.27 billion patacas a
year earlier, according to data released Tuesday by Macau's Gaming
Inspection and Coordination Bureau. The previous decline in gambling
revenue for the Chinese territory was in 2009.
Macau,
the only place in China where casinos are legal, has come under
pressure this year as slowing economic growth and a corruption crackdown
on the mainland cut into business from high-end gamblers.
For
weeks, analysts have warned investors to expect a disappointing June;
some expected a decline of as much as 5% in revenue for the month.
The Venetian Macao resort and casino on May 6.
Bloomberg News
The potential for a prolonged drop in
VIP revenue has spooked investors this year and sent stocks across the
sector to double-digit percentage declines. The Hong Kong-listed Macau
businesses of
Wynn Resorts Ltd.
WYNN +0.13%
and
MGM Resorts InternationalMGM -0.30%
are down 14% and 19%, respectively, so far in 2014, a sharp
comedown for stocks that were for years among the world's best
performers. The stocks didn't trade Tuesday because of a holiday in Hong
Kong.
Even the most bullish analysts
have warned of serious risks to Macau's VIP gambling business, which
drives two-thirds of the territory's $45 billion gambling industry.
Gaming-focused
research house Union Gaming in early June downgraded the sector to
hold, its first bearish call since starting coverage in early 2011. "We
absolutely love Macau but it's time to move to the sidelines," the firm
said in a note to clients.
should review the actions of the Justice in the below case and his court Attorney Stuart Davis.
The Caption of the case is incorrect, as Justice Friedlander signed a Stipulations So Ordering that Cecelia B Ratner be added as an Intervenor.
where ammunition and munitions are inexpensive widely available and BCG is not
The Italian Mafia and other family enterprises are considering the fine work of pubmed.org ristori + BCG to win the hearts minds and souls of people who believe that you can be a competent crook with character (good), something that has eluded pharmaceutical corporations. A corporation is by definition a person without a soul. Ditto for insurance companies. People are fungible.
The Price of Prevention: Vaccine Costs Are Soaring
Photo
PAINFUL MEDICINE
Rachel Chavez, left, and Beth Barnhart administer vaccines to Caius
Sims as his mother, Cedra Sims, helps hold him at Dr. Lindsay Irvin’s
office.Credit
Ben Sklar for The New York Times
SAN
ANTONIO — There is little that Dr. Lindsay Irvin has not done for the
children’s vaccines in her office refrigerator: She remortgaged her home
to afford their rising prices. She packed them in ice chests and moved
them when her office flooded this year. She pays a company to monitor
the fridge in case the temperature rises.
“The
security company can call me any time of the day or night so I can go
save my vaccines,” said Dr. Irvin, a pediatrician. Those in the
refrigerator recently cost $70,000, she said — “more than I paid for
four years of medical school.”
Vaccination
prices have gone from single digits to sometimes triple digits in the
last two decades, creating dilemmas for doctors and their patients as
well as straining public health budgets. Here in San Antonio and
elsewhere, some doctors have stopped offering immunizations because they
say they cannot afford to buy these potentially lifesaving preventive
treatments that insurers often reimburse poorly, sometimes even at a
loss.
As you read this article, please share your experiences by responding to the questions that will appear. Your responses will inspire future articles in this series.
Childhood immunizations are so vital to public health that the Affordable Care Act mandates their coverage
at no out-of-pocket cost and they are generally required for school
entry. Once a loss leader for manufacturers, because they are often more
expensive to produce than conventional drugs, vaccines now can be very
profitable.
Old
vaccines have been reformulated with higher costs. New ones have
entered the market at once-unthinkable prices. Together, since 1986,
they have pushed up the average cost to fully vaccinate a child with
private insurance to the age of 18 to $2,192 from $100, according to
data from the Centers for Disease Control and Prevention. Even with deep
discounts, the costs for the federal government, which buys half of all
vaccines for the nation’s children, have increased 15-fold during that
period. The most expensive shot for young children in Dr. Irvin’s
refrigerator is Prevnar 13, which prevents diseases caused by
pneumococcal bacteria, from ear infections to pneumonia.
Like
many vaccines, Prevnar requires multiple jabs. Each shot is priced at
$136, and every child in the United States is required to get four doses
before entering school. Pfizer, the sole manufacturer, had revenues of nearly $4 billion from its Prevnar
vaccine line last year, about double what it made from high-profile
drugs like Lipitor and Viagra, which now face generic competitors.
Dr. Lindsay Irvin keeps about 20 different vaccines, worth
about $34,000, in this refrigerator. This represents her current supply,
which is about half the value that would be present at the start of the
camp season or before school starts. A few of the most expensive and
common vaccines are listed.
Vaccines provided at no cost to doctors for children on Medicaid or who fall into certain medically underserved categories.
275 doses at $42
3RD SHELF TOTAL $11,610
FluMist
These were not used, and their value is a total loss. 90 doses at $22
4TH SHELF TOTAL $2,043
Varicella
Chickenpox. 43 doses at $94
FREEZER TOTAL $4,048
Michael
Haydock, an analyst at the London-based consulting firm Datamonitor
Healthcare, said no vaccine had ever been such a big seller. “It’s
expensive in part because it’s a very effective vaccine,” he said. “And
also because they’re exploiting their monopoly.”
That
does not sit well with many doctors. Even though the vaccine has not
changed, the price of the current version, Prevnar 13 (it protects
against 13 strains), has gone up an average of 6 percent each year since
it was approved by the Food and Drug Administration in 2010.
“You
have to make back your investment and pay your shareholders, but at
what point do you say, ‘Look, you’ve had your steak, gravy and potatoes
and this is enough?’ ” said Dr. Steven Black, a vaccine expert at
Cincinnati Children’s Hospital who served on the government committee
that recommended all children get Prevnar 7, an earlier version of the
vaccine.
To
deal with the rising prices, some doctors, who say they lose money on
every vaccination, reserve their shots for longstanding patients. A
survey of family-practice doctors, who along with pediatricians are
among the lowest-earning physicians, found that about one-third were
considering giving up immunizations because of the expense. Another survey found that 40 percent do not offer at least some required childhood immunizations.
That
is why Breanna Farris, a San Antonio mother, had to call 10
pediatricians in April before she found Dr. Irvin to vaccinate her son,
Traven, who is entering kindergarten this fall. The family’s usual
doctors do not offer vaccinations, and referred Ms. Farris to local
pharmacies (which do not vaccinate children) or the city health clinic
(which would not take Traven’s insurance).
“I
was like, ‘Where should I go?’ ” Ms. Farris said. “They say vaccines
are covered, but that isn’t really true if doctors aren’t giving them.”
Business Decisions
To
many pediatricians, not providing vaccines is as unthinkable as a baker
not selling bread. Before they became widely available in the mid-20th
century, tens of thousands of American children died each year from
diseases like polio, whooping cough and diphtheria. “It’s up there with
finding fire and the invention of the wheel,” said Dr. Irvin, 51, of
vaccines.
Photo
STAYING THE COURSE
Dr. Lindsay Irvin, examining Violet Ayala, continues to offer
vaccinations at a time when many of her colleagues have stopped doing
so.Credit
Ben Sklar for The New York Times
Vaccines work
by stimulating the body to develop immunity to a particular disease.
The process involves injecting a molecule under the skin that mimics the
virus or bacteria to prime the immune system to attack the real thing
when it arrives. Vaccines can contain a fragment of the pathogen or a
weakened version that can teach the immune system to recognize a germ,
without itself causing the disease.
The
earliest vaccines were not patented, in part because the law at the
time held that natural products could not be so protected. And vaccines like polio
were developed through a large infusion of government and foundation
funds, not by a company. Even when commercialized by the 1960s, vaccines
were made by small specialty manufacturers, instead of big
pharmaceutical firms, since producing them involved particular
challenges: using live organisms, some of them dangerous. Indeed, huge
liability payouts and aggressive mergers had, by the 1990s, meant that
more than half of the country’s vaccine makers had closed down. With low
retail prices, no one regarded vaccine making as a lucrative business.
When
he started his pediatric practice in 1982 in San Antonio, Dr. Michael
Ozer remembers, he charged $22 for a 2-month well-child checkup, with $8
added on for the polio vaccine and another $8 for the vaccine against
diphtheria, pertussis and tetanus. “And I’m sure we were making money on
it,” he said.
But
one by one, various barriers eroded: Drug manufacturers discovered new
ways to protect their products, like patenting the manufacturing
process. The number of vaccine patent applications rose tenfold in the
1990s to more than 10,000. In 1988, the federal government set up the Vaccine Injury Compensation Program, effectively shielding manufacturers and doctors.
And
the acceptable list price for drugs was rising. Vaccines, which
families often used to pay for out of pocket, are now typically covered
by insurance, and patients often do not notice the prices.
There
are, of course, some good reasons vaccines like Prevnar are more
expensive than previous offerings. Vaccine trials, which once included
thousands of volunteers, must now include tens, if not hundreds of
thousands of people, as fears about side effects like autism have grown,
even though many studies have concluded that such worries are unfounded. Some of the newer vaccines are complicated to manufacture.
Photo
Oskar Lozano, 4 months old, gets a checkup by Dr. Michael Ozer before getting his vaccines in San Antonio.Credit
Ben Sklar for The New York Times
Prevnar,
for example, involves attaching a piece of a dangerous bacterium’s
outer layer to a protein that renders it better able to provoke a
protective immune reaction in babies. And because it covers 13 strains
of the disease, it is in some ways 13 vaccines in one.
Pfizer
maintains that Prevnar’s prices are justified because of its investment
in “one of the most complex biologic products ever developed and
manufactured,” said Sally Beatty, a company spokeswoman. She noted that
it takes five years and costs $600 million to build a vaccine
manufacturing site, and that one batch of Prevnar 13 takes two years to
create, with more than 500 quality control tests. Development of the
first Prevnar vaccine took 14 years, Ms. Beatty said, from the
initiation of research to licensing. (That work occurred before Pfizer
acquired the Prevnar brand in 2009 when it bought Wyeth Laboratories, which had in turn acquired it from smaller companies.)
“It’s
a risky business developing vaccines, so you can explain — if not
necessarily justify — the higher costs of vaccination,” said Dr. Alan
Hinman, a former head of the immunization division of the C.D.C. and now
a senior scientist at the Task Force for Global Health in Georgia. “A
more difficult question is, after the research and development costs are
recouped, why don’t prices come down?”
For
a 2-month well-child checkup in 2014, Dr. Ozer charges $115. And the
vaccine charges have grown to $725, for which insurers like Blue
Cross/Blue Shield reimburse $613.79.
Cost vs. Benefit
For
most prescription medicines, the crucial hurdle to marketing is to win
Food and Drug Administration approval. But for vaccines, the prize is
the imprimatur of the federal Advisory Committee on Immunization Practices.
Once a shot is on the committee’s schedule as mandatory, everychild has
to get it before entering school and insurers have to cover it, at
least nominally. (Many states require home-schooled children to be
vaccinated as well.) “We have to give it to every kid, so it’s a golden
ticket,” Dr. Irvin said.
That
requirement is a powerful incentive: Last year, Ms. Farris’s older
child, Lenna, missed the first week of school as Ms. Farris, then new to
Texas, searched for a provider willing to vaccinate the girl.
Desperate, Ms. Farris took her daughter to a public health clinic and
lied, saying she had no insurance. She found Dr. Irvin to immunize her
son only this year.
Photo
‘WHERE SHOULD I GO?’ Breanna Farris searched frantically for doctors to immunize her children, Traven, left, and Lenna.Credit
Ben Sklar for The New York Times
The
value of that “school mandate” is also apparent in the pricing. When
Singapore’s national vaccine advisory group evaluated Prevnar 7 for
mandated use, its price was about $80, said Karen Tyo, a researcher from
Brandeis University, who was advising the government. After the
government included it in the required national schedule, “the price
jumped immediately” to about $120, she said. “Nothing had changed,” she
noted. “It didn’t make any sense.”
To
evaluate new vaccines for inclusion on mandated lists, national vaccine
panels assess a vaccine’s cost benefit ratio. (F.D.A. approval requires
that companies show vaccines are “safe and effective.” Cost is not
considered.) Will the cost of buying and administering the vaccine
result in a substantial payback for patients and society at large? That
is a complicated, often nebulous, calculation.
Even
before the advent of Prevnar, children under 5 rarely died of
pneumococcal illness — about 200 in the United States annually,
according to the C.D.C. So, in urging countries to adopt Prevnar 13,
Pfizer produced extensive studies emphasizing the vaccine’s broad
indirect benefits, such as reductions in a parent’s lost work time as
well as the fact that the grandparent of an immunized baby is less
likely to contract the disease. The company also factored in the ear
infections Prevnar might prevent in children, even though most of those
could be treated with antibiotics.
For
example, one Pfizer study concluded that in the United States in 2009,
Prevnar prevented 2.3 million cases of pneumococcal disease, 5,056
deaths of all ages and saved $965 million in direct costs and $2.7
billion in societal costs.
But
when Prevnar 7 was first evaluated in 2000 for universal vaccination of
children in the United States, the vaccine advisory committee concluded
it was not likely to be cost effective, said Dr. Black, who was on the
panel. In a study around that time, Dr. Black and colleagues concluded
that the vaccine would result in cost saving for society only if each
dose was priced at $46. It entered the market, though, at $58 a shot.
Photo
The DTap, MMR, Prevnar 13 and Hep A vaccines.Credit
Ben Sklar for The New York Times
The
committee decided to approve it anyway because it would save a few
families from the tragedy of an infant’s death; the vaccine later proved
more effective than the study had anticipated.
The
Swiss Agency for Therapeutic Products pays $101, a price that has not
changed over time. In Britain, the small private health care market
sells prefilled syringes of Prevnar 13 for an average of $82 at
pharmacies; the National Health Service pays even less, experts say.
Prefilled syringes cost an average of $136 in the United States, and
even the C.D.C. — which buys vaccines for the Medicaid program at a
discount — pays $112.84.
Other
countries have also diverged from the United States in how they deploy
Prevnar 13, generally giving only three shots instead of four. Studies
have shown that the protection is almost as good, particularly against
the serious forms of the disease. “There’s virtually no benefit,” Dr.
Black said. “We’re basically paying an extra $100-plus per child for
nothing.”
Every
week or two, Dr. Irvin sits down at her computer to buy vaccines. With
more than 3,000 patients in her practice, she estimates that it would
cost her $70,860 a month to be fully stocked with vaccines for any
patient who walked in the door. Instead, she buys sparingly for
scheduled appointments and looks for manufacturers’ bargains.
Online,
there are back-to-school sales, closeout sales on last year’s models
and discounts for early booking. Dr. Irvin buys vaccines for polio,
whooping cough, tetanus and hemophilus meningitis from Sanofi-Pasteur on
a site called the Vaccine Shoppe. “I feel like I’m going to a boutique,” she commented while completing a recent purchase.
Because
Dr. Irvin belongs to a purchasing cooperative of Texas pediatricians,
the prices are often discounted 5 to 10 percent from the list price. But
rates often fluctuate: On the Merck website, she noticed that the price
of the vaccine against human papillomavirus had gone up from the
previous week. She decided to buy vials rather than prefilled syringes
because she would save about $1.50 a dose on a price of $132.46 a shot.
“That’s make or break it,” she noted.
Dr. Lindsay Irvin is a pediatrician in
San Antonio, Tex., who says providing vaccines is a financial risk and
strain for doctors.
Publish Date July 2, 2014.
Likewise
she buys vials, rather than syringes, for the measles, mumps, rubella
vaccine to lower the cost to $51.20 a dose. In 2002, the same vaccine
was $27.70 for private doctors. Because some companies, like Pfizer,
require that each physician sign a legal agreement not to disclose the
price he or she paid, there is little informed shopping. “I was kind of
aghast, I didn’t think it could be legal, but it is,” said Dr. Gary L.
Freed, a pediatrician at the University of Michigan School of Public
Health who has studied vaccine purchases. “And it’s certainly a very
inefficient market since it means physicians don’t have information to
bargain.”
The
result is much like that in other aspects of American medicine: Huge
price variations for the same item or service. Large group practices
that have purchasing clout with drug makers and insurers may make a
profit from providing vaccines, while solo practices, like Dr. Irvin’s,
can incur losses. Some doctors pay three times as much as others in the
same city, Dr. Freed’s studies have found. One large practice was
yielding $39 per dose of Prevnar, while 11 percent of practices were
losing money on it.
Private
insurers pay doctors a median of $145 for Prevnar, according to data
compiled by Athena Health. Dr. Jeffrey J. Cain, the board chairman of
the American Academy of Family Physicians, noted that reimbursement from
insurers runs between 40 and 100 percent of the vaccine’s purchase
cost, which often does not allow for overhead such as insurance, storage
and the computer record-keeping systems required by the federal
government.
Dr. Irvin says she loses money every time she gives a shot.
see also fasutmanlab.org and pubmed.org faustman dl
Teamsters President Local 707 Kevin McCaffrey who is also a Suffolk County Legislator.
At teach general meeting of Teamsters Local 707 members ask when the Local's pension plan is going to be taken over by the PBGC. The next General Meeting is likely to be Sunday July 27. Submit your questions here and send along a video recorder for your mail order answers. Nassau OTB employees are members of Teamsters Local 707. It is great to collect cash and ...... Nassau OTB employees who work one or two shifts a week pay the same dues as workers who work 40 hours a week? Fair is fare?
Federal Pension-Plan Safety Net Faces Severe Funds Squeeze
Pension Benefit Guaranty Corp. Estimates the Program Could Collapse Within 10 Years
By
John D. McKinnon
June 30, 2014 7:07 p.m. ET
The federal safety net for a type of
private-sector pension plan common in the transportation, construction
and other industries is at risk of collapse in coming years, according
to a report released Monday.
Such an outcome has the potential to affect more than a million people.
The
federal Pension Benefit Guaranty Corp. program that covers
multi-employer pensions "is more likely than not to run out of funds in
eight years, and highly likely to do so within 10 years," the agency
said in releasing new projections. The PBGC collects insurance premiums
from employers that offer the pensions and helps retirees in insolvent
plans by paying them reduced pensions.
But
the likely failure of several big plans means that the PBGC's limited
resources for helping retirees in failed multi-employer plans likely
will be tapped out in coming years. This year's report estimates that
the $8.3 billion long-term deficit the federal backup plan for
multi-employer plans faced in fiscal year 2013 will widen to $49.6
billion by fiscal year 2023. The deficits don't mean that the backup
plan can't pay now.
The PBGC's new
projections "show that insolvencies affecting more than a million of the
10.4 million people in multi-employer plans are now both more likely
and more imminent," the PBGC said.
This
year's PBGC projections rely on a new methodology that the agency
regards as more realistic about what troubled pension funds can and
can't do to shore themselves up—for instance, plans could raise
employer-contribution requirements, but that would tend to drive off
remaining participants, accelerating the downward spiral.
The
report underscores growing pressure on Congress to take action. But the
options for lawmakers are politically difficult. Bailouts of troubled
plans or of the safety-net program itself could spark a backlash among
voters, while forcing benefit cuts on beneficiaries—particularly current
retirees—would be painful and unpopular.
Republican
and Democratic leaders of the House Education and the Workforce
Committee Chairman took the unusual step of issuing a joint statement
Monday. They have been negotiating a solution but so far without
success.
"The latest PBGC report
confirms in stark detail the significant challenges confronting the
multi-employer pension system," said the statement from Chairman
John Kline
(R., Minn.) and ranking Democrat
George Miller
of California, along with other members. "The systemic crisis we
face threatens countless workers, employers, and retirees, and could
ultimately harm American taxpayers, as well. We have an obligation to
advance reforms that will modernize the system, encourage employer
participation, protect taxpayers, and offer new tools to help rescue
troubled plans. We continue to work together to find common ground and a
responsible legislative solution."
Senate Finance Committee Chairman
Ron Wyden
(D., Ore.) also expressed new worry.
"I'm
very concerned by the findings…issued today by the Pension Benefit
Guaranty Corporation," Mr. Wyden said in a statement Monday. "The report
confirms what we already know—the multiemployer pension plan system is
in big trouble and putting a significant strain on the PBGC. As I've
stated previously, the Finance Committee is taking a hard look at the
issues surrounding multiemployer pension plans, and I will work with my
colleagues to address these issues in order to protect Americans' earned
retirement benefits."
Problems with
multi-employer pension plans—in which numerous employers in the same
industry typically contribute to a single pension fund—have been
recognized for years. Many of the funds were established through union
contracts in industries that have undergone significant upheaval in
recent decades, such as trucking and coal mining.
That
restructuring has led to fewer employers making payments to the funds
on behalf of fewer workers. Federal oversight also continues to be
light, and the PBGC collects relatively low premiums to back up the
multi-employer plans.
UNIONS
have never been uncontroversial in American society, but the battles
over labor have grown fiercer in recent years: Witness the fight over
public-employee unions in Wisconsin, or the 2012 decision by Michigan
lawmakers to join the ranks of “right to work” states.
On
Monday a 5-to-4 majority of the Supreme Court fired its own salvo in
the war on unions. Though its decision in Harris v. Quinn was narrow,
saying that, in some cases, unions could not collect fees from one
particular class of public employees who did not want to join, its
language suggests that this may be the court’s first step toward
nationalizing the “right to work” gospel by embedding it in
constitutional law.
The
petitioners in Harris were several home-care workers who did not want
to join a union, though a majority of their co-workers had voted in
favor of joining one. Under Illinois law, they were still required to
contribute their “fair share” to the costs of representation — a
provision, known as an “agency fee,” that is prohibited in “right to
work” states.
The
ability of unions to collect an agency fee reflects a constitutional
balance that has governed American labor for some 40 years: Workers
can’t be forced to join a union or contribute to its political and
ideological activities, but they can be required to pay for the cost of
the union’s collective bargaining and contract-administration
activities.
The
majority in Harris saw things differently. Making workers pay anything
to a union they oppose is in tension with their First Amendment rights —
“something of an anomaly,” in the words of the majority. But the real
anomaly lies in according dissenters a right to refuse to pay for the
union’s services — services that cost money to deliver, and that put
money in the pockets of all employees.
Once
selected by a majority of workers in a bargaining unit, a union becomes
the exclusive representative, with a duty to fairly represent all of
them. That is the bedrock of our public and private sector labor laws.
Unless
everyone is required to pay for those services, individual workers can
easily become “free riders,” taking the benefits of collective
representation without paying their fair share of the costs. Not only
dissenters but any employee who wants to save a buck can “free ride.”
The net result may be that the union cannot afford to represent workers
effectively, and everyone suffers.
Consider
the home-care providers at issue in Harris. These workers, who are in
one of the fastest-growing and lowest-paid occupations in America, are
generally employed solely by individual customers, even when their wages
came from public funds like Medicaid. Alone, they were stuck with low
pay and meager benefits, and states faced labor shortages and high
turnover.
Several
years ago Illinois, like several other states, took on the role of
joint employer, along with individual customers, of the care workers.
That enabled them to vote on joining a union. They did so, and as a
result nearly doubled their wages and secured state-funded health
insurance, as well as training and safety provisions.
All
of Illinois’s in-home care providers benefit from union representation.
Until Monday, all were required to pay a modest fee for those services.
But now workers can “free ride.”
While
a majority declined to strike down agency-fee arrangements for
“full-fledged” public employees, as the petitioners had requested, and
as unions had feared, the majority makes clear that such fees now rest
on shaky constitutional ground, at least in the public sector, and are
vulnerable to broader attack in the future.
The
ability of unions to survive rests on whether they solve the “free
rider” problem. That is why mandatory fees have been a critical
battleground for unions and their antagonists for over 70 years. The
antagonists have won many of those battles, beginning with the
state-level “right-to-work” laws that bar any mandatory union fees.
The
First Amendment framework used by the “right to work” movement — and
now by much of the Supreme Court — to mount this attack is something old
masquerading as something new. Similar arguments were made during the
19th century, when rising inequalities between individual workers and
increasingly large-scale industrial employers led workers to invent
unions and collective bargaining. For decades, employers found a willing
ally in the court: When Congress or state legislatures passed laws
protecting workers’ freedom to organize and bargain collectively, the
court struck them down in the name of “liberty of contract.”
This
changed in the 1930s, when the New Deal court finally conceded the
constitutional bona fides of “industrial democracy” through majority
rule. But now the court’s conservative majority has taken a bold step
backward, recasting the individualist crusade as a battle between
compelled speech and the right to refrain from speech — between
individual dissent and collective compulsion. But in substance it is the
same old fight between the right of workers to bargain collectively and
the individual liberty of contract.
Unions
are already reeling. At a time when workers are losing economic ground,
we should be looking for ways to strengthen their ability to join with
co-workers and bargain collectively to improve their lot. Instead, the
court in Harris sided with those who seek to weaken it further.
Correction: July 3, 2014
An earlier version of this article mischaracterized Michigan’s
2012 decision to become a “right to work” state. It was made by state
lawmakers, not directly by voters.
Cynthia Estlund
Catherine A. Rein Professor of Law
New York University School of Law
40 Washington Square South, 403B
New York, NY 10012
NYC OTB, now deceased, and the public benefit corporations of New York State present labor issues that may be unique to NY?
Long Island Business News
Suffolk,
Nassau
OTB probe ethics conflict
by David Winzelberg
Published: November 24th, 2013
At least one employee of Nassau County Off-Track
Betting is questioning whether the head of his employee
union, a
member-elect of the Suffolk
County Legislature, should have a say in Suffolk OTB
business.
Teamsters Local
707 President
Kevin McCaffery, whose union represents about 200 Nassau OTB
workers,
was elected earlier this month to serve as a Suffolk
legislator
representing the 14th District. In a letter last week, Nassau
OTB
cashier Jackson Leeds alerted the Suffolk County Ethics Board
to
McCaffery’s possible conflict of interest.
“As a Suffolk County legislator, his duties are to the people
of
Suffolk County,” Leeds wrote. “He cannot simultaneously
represent the
interests of employees of Nassau OTB, a Nassau County public
benefit
corporation.”
McCaffery told LIBN he doesn’t think the two counties’ OTBs
are in
competition with each other and he doesn’t see his role as
union leader
for Nassau OTB workers as a conflict with issues surrounding
Suffolk
OTB.
“If anything, I have the background of dealing with Nassau
OTB, which
gives me more insight on the subject than any other legislator
out
there,” McCaffery said.
When asked if the legislator-elect’s union job appeared to be
a
conflict of interest, Nassau OTB chief Joseph Cairo said, “If
you
really want to stretch it. But I don’t see anything that’s
apparent to
me.”
Cairo added that he’ll instruct the Nassau agency’s counsel to
review
the situation.
Leeds, a 10-year veteran of Nassau OTB, complained that both
union
officials and county OTB management have been too focused on
the 1,000
video lottery terminals planned for each county’s OTB and
they’re not
paying enough attention to current operations.
“They never worked behind a window,” Leeds told LIBN. “They’re
out of
touch with the bettors of Nassau County.”
Internet wagering and dwindling handles – the overall money
being
wagered – have prompted a consolidation in Nassau OTB’s
operations in
recent years; there were 15 betting offices in Nassau in 2003,
and now
there are eight. Suffolk OTB, which has seven branch offices,
filed for
bankruptcy last year.
These days, according to some analysts, OTB offices exist
largely for
political patronage – another reason, according to Leeds, that
the
Nassau union chief shouldn’t mix one business with the other.
“Union leaders should not be politicians,” he said. “OTBs are
run by
politicians. Being political and doing public good aren’t
always
incompatible, but they often are.”
This isn’t the first time a Long Island legislator’s OTB ties
have
become an issue.
In May 2000, Gregory Peterson, then-president of the Nassau
OTB, sued
to prevent Nassau County Leg. Roger Corbin from voting on
appointments
to the Nassau OTB’s board of directors. Because Corbin was
employed as
a branch manager for New York City OTB and a member of
Teamsters Local
858, which then represented all employees of Nassau OTB,
Peterson
alleged Corbin’s legislative role posed a conflict of
interest.
A New York Supreme Court judge issued an injunction preventing
Corbin
from voting on OTB appointments, but Corbin appealed and the
lower
court’s decision was reversed. The Nassau County Board of
Ethics also
chimed in, determining by a 3-2 vote that voting on OTB
appointments
didn’t create a conflict because Corbin didn’t influence
policy or
engage in labor negotiations.
With McCaffery, some observers say it’s best to proceed with
caution.
Anthony Figliola, vice president of Uniondale-based government
relations firm Empire
Government
Strategies, said the legislator-elect may want to recuse
himself
from any votes concerning Suffolk OTB until the Suffolk County
Ethics
Board offers an opinion.
“OTB is a political football,” Figliola said. “It’s better to
stay out
of it, especially if you want to get things done in the
Legislature.”
on Roman Catholic Palm Sunday and Easter Sunday because Nassau OTB loves only slot machines?
Slot machines, another form of onanism?
Puerto Rico's debt restructuring firm spotted in Mineola
Nassau OTB seeks firm to aid in picking mini-casino location
Originally published: July 3, 2014 6:30 PM
Updated: July 3, 2014 8:42 PM
By ROBERT BRODSKYrobert.brodsky@newsday.com
Nassau Regional Off-Track Betting wants to hire a
firm to study potential locations the agency is considering for a
mini-casino with 1,000 video slot machines and electronic table games.
(Credit: Nancy Borowick, 2012)
Nassau Regional Off-Track Betting wants to hire
a firm to study locations the agency is considering for a mini-casino
with 1,000 video slot machines and electronic table games.
Nassau OTB will release a Request for
Statements of Qualifications on Monday seeking a firm with architectural
and engineering experience that can analyze a handful of locations
under consideration for the gaming parlor.
The firm will examine the condition of
the buildings; any costs to fix electrical, plumbing, heating, air
conditioning and sewer systems; and whether there is sufficient parking. RESULTS: Votes totals in all races DATA:Contributions in Nassau Executive race | Contributions in NYC Mayor's race | See how LI reps voted on issues | Contributions to local GOP in Nassau MORE:Full coverage
The cost to build a large bar in the center of the gaming parlor will also be calculated, Nassau OTB president Joe Cairo said.
"We are looking at several sites, so we need someone with expertise and background in this field," Cairo said.
Bids are due July 14, and OTB expects to select a review firm quickly.
The agency is considering as many as
five sites that OTB would purchase to build the county's first gaming
parlor. Cairo declined to identify the sites but said a decision could
come by the end of the month.
The proposed site must have at least 100,000 square feet of usable space, including 50,000 square feet on the ground floor.
Once a site is selected, OTB is
considering issuing a Request for Proposals for a private operator to
run the parlor, Cairo said. The agency could also choose to hire several
experienced individuals to manage the facility, he said.
Cairo hopes to open the gaming parlor next year. Nassau expects the facility to generate $19 million in 2015.
The state last year granted Nassau and
Suffolk counties authority to build one gaming site each with up to
1,000 video lottery terminals, which include slot machines and table
games such as roulette, baccarat and blackjack.
Suffolk has selected Delaware North, a
Buffalo-based gaming and hospitality company, to operate its casino,
but has yet to select a site for its parlor.